What is the ticker symbol for Coeptis Therapeutics?

Coeptis Therapeutics trades under the ticker COEPW on NASDAQ.

What sector does Coeptis Therapeutics operate in?

Coeptis Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze COEPW in a portfolio?

PortView shows COEPW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Coeptis Therapeutics (COEPW) Stock Analysis

NASDAQHealthcareBiotechnology

$0.01+0.00%

1-year price historyRange $0.01 – $0.04

52-week range$0.01

$0.01$0.03

What Coeptis Therapeutics does

Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company dedicated to advancing both innovative cell therapy platforms and a pipeline of generic and branded pharmaceutical products, primarily targeting cancer patients. Its leading oncology assets include CD38-GEAR-NK, a Vy-Gen drug candidate engineered to combat CD38-positive cancers such as multiple myeloma, chronic lymphocytic leukemia (CLL), and acute myeloid leukemia (AML). Alongside this, the company offers CD38-Diagnostic, an in vitro screening tool designed to identify cancer patients who are most likely to respond favorably to targeted anti-CD38 monoclonal antibody treatments. Beyond its internal pipeline, Coeptis also engages in strategic partnerships. It collaborates with Statera BioPharma on the development and commercialization of STAT-201 for Crohn's disease. Additionally, it holds co-development and ownership rights for CPT60621, a potential therapy for Parkinson's Disease, through a collaboration with Vici Health Sciences, LLC. Established in 2017, the company maintains its headquarters in Wexford, Pennsylvania.

Key metrics

Market cap

$64,721

P/E (TTM)

0.00

EPS (TTM)

$0.00

Beta

2.42

Dividend yield

0.00%

Revenue / share

$0.06

50-day avg

$0.01

200-day avg

$0.02

52-week high

$0.03

52-week low

$0.01

CEO

David Mehalick

ETFs linked to COEPW

Broad-market and Healthcare sector ETFs an investor holding Coeptis Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how COEPW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze COEPW in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Coeptis Therapeutics?: Coeptis Therapeutics trades under the ticker COEPW on NASDAQ.
Which exchange is COEPW listed on?: COEPW is listed on NASDAQ.
What sector does Coeptis Therapeutics operate in?: Coeptis Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze COEPW in a portfolio?: PortView shows COEPW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.